- Home
- Publications
- Publication Search
- Publication Details
Title
Coupling factors involved in preserving bone balance
Authors
Keywords
Bone remodeling, Coupling factor, Axon guidance molecule, Therapeutic target, Biomarker
Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-12-04
DOI
10.1007/s00018-018-2981-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Understanding axon guidance: are we nearly there yet?
- (2018) Esther T. Stoeckli DEVELOPMENT
- WAIF1 Is a Cell-Surface CTHRC1 Binding Protein Coupling Bone Resorption and Formation
- (2018) Kazuhiko Matsuoka et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Opening windows for bone remodeling through a SLIT
- (2018) Jameel Iqbal et al. JOURNAL OF CLINICAL INVESTIGATION
- Osteoclast-secreted SLIT3 coordinates bone resorption and formation
- (2018) Beom-Jun Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Direct cell–cell contact between mature osteoblasts and osteoclasts dynamically controls their functions in vivo
- (2018) Masayuki Furuya et al. Nature Communications
- Coupling of bone resorption and formation by RANKL reverse signalling
- (2018) Yuki Ikebuchi et al. NATURE
- Receptor becomes a ligand to control bone remodelling
- (2018) Mone Zaidi et al. NATURE
- Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned
- (2017) Matthew T Drake et al. ENDOCRINE REVIEWS
- Sphingosine 1-phosphate signaling in bone remodeling: multifaceted roles and therapeutic potential
- (2017) Anastasia Meshcheryakova et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Coupling of Bone Resorption and Formation in Real Time: New Knowledge Gained From Human Haversian BMUs
- (2017) Nicolai Ernlund Lassen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bone-targeted delivery of nanodiamond-based drug carriers conjugated with alendronate for potential osteoporosis treatment
- (2016) Tae-Kyung Ryu et al. JOURNAL OF CONTROLLED RELEASE
- Semaphorin signaling in bone
- (2016) Lieve Verlinden et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Merck & Co. drops osteoporosis drug odanacatib
- (2016) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study
- (2016) S. J. Bae et al. OSTEOPOROSIS INTERNATIONAL
- Semaphorin Signaling in Cardiovascular Development
- (2015) Jonathan A. Epstein et al. Cell Metabolism
- Netrin-1 Is a Critical Autocrine/Paracrine Factor for Osteoclast Differentiation
- (2015) Aránzazu Mediero et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Risks and Benefits of Bisphosphonate Therapies
- (2015) Carlen Reyes et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Axon guidance proteins in neurological disorders
- (2015) Eljo Y Van Battum et al. LANCET NEUROLOGY
- The effect of sphingosine-1-phosphate on bone metabolism in humans depends on its plasma/bone marrow gradient
- (2015) B.-J. Kim et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Coupling Signals between the Osteoclast and Osteoblast: How are Messages Transmitted between These Temporary Visitors to the Bone Surface?
- (2015) Natalie A. Sims et al. Frontiers in Endocrinology
- Odanacatib: a review of its potential in the management of osteoporosis in postmenopausal women
- (2015) Roland D. Chapurlat Therapeutic Advances in Musculoskeletal Disease
- A Comparison of Osteoclast-Rich and Osteoclast-Poor Osteopetrosis in Adult Mice Sheds Light on the Role of the Osteoclast in Coupling Bone Resorption and Bone Formation
- (2014) Christian S. Thudium et al. CALCIFIED TISSUE INTERNATIONAL
- Semaphorin signalling during development
- (2014) B. C. Jongbloets et al. DEVELOPMENT
- Osteoclast-Derived Complement Component 3a Stimulates Osteoblast Differentiation
- (2014) Kazuhiko Matsuoka et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Serum Sema3A Is in a Weak Positive Association With Bone Formation Marker Osteocalcin But Not Related to Bone Mineral Densities in Postmenopausal Women
- (2014) Dong-mei Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bone marrow mesenchymal stem cells and TGF-β signaling in bone remodeling
- (2014) Janet L. Crane et al. JOURNAL OF CLINICAL INVESTIGATION
- Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial
- (2014) H. G. Bone et al. OSTEOPOROSIS INTERNATIONAL
- Understanding Coupling between Bone Resorption and Formation
- (2013) Thomas L. Andersen et al. AMERICAN JOURNAL OF PATHOLOGY
- The Bone Resorption Inhibitors Odanacatib and Alendronate Affect Post-Osteoclastic Events Differently in Ovariectomized Rabbits
- (2013) Pia Rosgaard Jensen et al. CALCIFIED TISSUE INTERNATIONAL
- Osteoclast-Derived Coupling Factors in Bone Remodeling
- (2013) Kim Henriksen et al. CALCIFIED TISSUE INTERNATIONAL
- SnapShot: Axon Guidance
- (2013) R. Jeroen Pasterkamp et al. CELL
- Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation
- (2013) Sutada Lotinun et al. JOURNAL OF CLINICAL INVESTIGATION
- Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation
- (2013) Sunao Takeshita et al. JOURNAL OF CLINICAL INVESTIGATION
- Sema3A regulates bone-mass accrual through sensory innervations
- (2013) Toru Fukuda et al. NATURE
- Osteopetrosis: genetics, treatment and new insights into osteoclast function
- (2013) Cristina Sobacchi et al. Nature Reviews Endocrinology
- A specific subtype of osteoclasts secretes factors inducing nodule formation by osteoblasts
- (2012) Kim Henriksen et al. BONE
- Afamin secreted from nonresorbing osteoclasts acts as a chemokine for preosteoblasts via the Akt-signaling pathway
- (2012) Beom-Jun Kim et al. BONE
- Higher Circulating Sphingosine 1-Phosphate Levels Are Associated with Lower Bone Mineral Density and Higher Bone Resorption Marker in Humans
- (2012) Seung Hun Lee et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Osteoprotection by semaphorin 3A
- (2012) Mikihito Hayashi et al. NATURE
- Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells
- (2012) Lingling Xian et al. NATURE MEDICINE
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2012) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Intercellular Cross-Talk Among Bone Cells: New Factors and Pathways
- (2012) Natalie A. Sims et al. Current Osteoporosis Reports
- GP130 cytokines and bone remodelling in health and disease
- (2011) Natalie A. Sims et al. BMB Reports
- Nervous vascular parallels: axon guidance and beyond
- (2011) Marco Arese et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Osteoporosis: now and the future
- (2011) Tilman D Rachner et al. LANCET
- Matrix-embedded cells control osteoclast formation
- (2011) Jinhu Xiong et al. NATURE MEDICINE
- Suppression of bone formation by osteoclastic expression of semaphorin 4D
- (2011) Takako Negishi-Koga et al. NATURE MEDICINE
- Control of Bone Resorption by Semaphorin 4D Is Dependent on Ovarian Function
- (2011) Romain Dacquin et al. PLoS One
- Regulation of immune cell responses by semaphorins and their receptors
- (2010) Hyota Takamatsu et al. Cellular & Molecular Immunology
- Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo
- (2010) Masaru Ishii et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Chemorepellent Slit3 Promotes Monocyte Migration
- (2010) S. B. Geutskens et al. JOURNAL OF IMMUNOLOGY
- Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies
- (2009) S A Stoch et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Odanacatib, a Cathepsin-K Inhibitor for Osteoporosis: A Two-Year Study in Postmenopausal Women With Low Bone Density
- (2009) Henry G Bone et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Non-resorbing osteoclasts induce migration and osteogenic differentiation of mesenchymal stem cells
- (2009) L. Kreja et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis
- (2009) Masaru Ishii et al. NATURE
- TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
- (2009) Yi Tang et al. NATURE MEDICINE
- A Physical Mechanism for Coupling Bone Resorption and Formation in Adult Human Bone
- (2008) Thomas Levin Andersen et al. AMERICAN JOURNAL OF PATHOLOGY
- Osteoclast–osteoblast communication
- (2008) Koichi Matsuo et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Osteoclasts secrete non-bone derived signals that induce bone formation
- (2008) Morten A. Karsdal et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K
- (2008) Jacques Yves Gauthier et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Eph-Ephrin Bidirectional Signaling in Physiology and Disease
- (2008) Elena B. Pasquale CELL
- Advances in osteoclast biology resulting from the study of osteopetrotic mutations
- (2008) T. Segovia-Silvestre et al. HUMAN GENETICS
- Cardiotrophin-1 Is an Osteoclast-Derived Stimulus of Bone Formation Required for Normal Bone Remodeling
- (2008) Emma C Walker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sphingosine-1-phosphate acts as a developmental stage specific inhibitor of platelet-derived growth factor-induced chemotaxis of osteoblasts
- (2008) T. Roelofsen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Osteoclasts Control Osteoblast Chemotaxis via PDGF-BB/PDGF Receptor Beta Signaling
- (2008) Maria Arantzazu Sanchez-Fernandez et al. PLoS One
- Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate
- (2008) L. Pederson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started